Does RITONAVIR Cause Interstitial lung disease? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Interstitial lung disease have been filed in association with RITONAVIR (Norvir). This represents 0.1% of all adverse event reports for RITONAVIR.
14
Reports of Interstitial lung disease with RITONAVIR
0.1%
of all RITONAVIR reports
0
Deaths
13
Hospitalizations
How Dangerous Is Interstitial lung disease From RITONAVIR?
Of the 14 reports, 13 (92.9%) required hospitalization.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RITONAVIR. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does RITONAVIR Cause?
Foetal exposure during pregnancy (1,980)
Maternal exposure during pregnancy (927)
Exposure during pregnancy (871)
Drug interaction (709)
Virologic failure (594)
Premature baby (542)
Death (476)
Abortion spontaneous (453)
Drug resistance (445)
Off label use (382)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which RITONAVIR Alternatives Have Lower Interstitial lung disease Risk?
RITONAVIR vs RITUXAN
RITONAVIR vs RITUXIMAB
RITONAVIR vs RITUXIMAB-ABBS
RITONAVIR vs RITUXIMAB-ARRX
RITONAVIR vs RITUXIMAB-PVVR